In Conversation

Hector Valle – CEO, FUNSALUD

Hector Valle – CEO, FUNSALUD

We are confident that Claudia Sheinbaum and her team understand what needs to be done [in terms of healthcare] and are capable of swiftly initiating the necessary actions
Xueming Qian – CEO & Co-Founder, Transcenta

Xueming Qian – CEO & Co-Founder, Transcenta

China has become a vibrant hub for innovation, yielding numerous first-in-class molecules. We are proud to possess such molecules ourselves and are actively engaging with multinational partners
Walid Tohme – Partner, Strategy& Middle East, PwC

Walid Tohme – Partner, Strategy& Middle East, PwC

Aligning multiple stakeholders in Saudi Arabia's healthcare transformation is pivotal yet challenging. With the creation of new entities alongside the transformation of existing ones, establishing cohesive governance and operational models becomes crucial
Guillaume Delmotte – General Manager, Ipsen China

Guillaume Delmotte – General Manager, Ipsen China

Moving [our China headquarters] to Shanghai allowed Ipsen to start afresh and build a new legacy
Paul Stoffels – CEO & Chairman, Galapagos

Paul Stoffels – CEO & Chairman, Galapagos

The complexities of conditions like cancer demand a revolutionary solution. That is where CAR-T cell therapy could be a potential game-changer
Sabrina Chan – Senior Executive Director, Hong Kong Association of the Pharmaceutical Industry (HKAPI)

Sabrina Chan – Senior Executive Director, Hong Kong Association of the Pharmaceutical Industry (HKAPI)

What is critical here is to ensure Hong Kong's regulatory framework remains aligned with international standards and being recognized by many markets
Nuno Sousa – President, 2CA-Braga

Nuno Sousa – President, 2CA-Braga

A collaborative environment … can potentially position Portugal on par with Spain in the clinical research landscape within the next five years
Saudi Procurement Body Goes Digital

Saudi Procurement Body Goes Digital

[NUPCO's] initiatives contribute to enhancing Saudi Arabia's position as a leading regional centre for the pharmaceutical and biotechnology industry
Mohal Sarabhai – Managing Director, ASE

Mohal Sarabhai – Managing Director, ASE

We actively sought out synergies in the diagnostic business and view partnerships as a means to avoid reinventing the wheel  
See more

In Case You Missed It

InFigures

Apart from a maturing regulatory environment and the expansion of healthcare coverage across the region, a number of other factors are contributing to the evolution of the MEA pharma market. Results from the second wave of a PhRMA-commisioned IQVIA market access study covering Saudi Arabia (KSA), UAE, Kuwait, Lebanon, Jordan, Egypt, Algeria, Morocco, Tunisia and…

As Big Pharma makes evermore declarations on its sustainability credentials, who are the industry’s most sustainable companies? With wildlife under severe threat from biopharmaceutical run-off, which companies are truly dedicated to change? Which are truly dedicated to equitable pay structures and promoting diversity, equity and inclusion? To answer these questions, the Toronto-based media and research…

Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant.  As a recent study from Deloitte sponsored by the Belgian pharmaceutical industry association, pharma.be, shows, Belgium is also a leader in clinical trials, maintaining its…

Latin America will be the world’s fastest growing region for pharmaceuticals up to 2027, with a stunning expected compound annual growth rate of 22 percent, according to recent reporting from IQVIA. The Indian subcontinent can also expect sizeable growth over the next three years, although the US, Europe, and East Asia will remain the largest…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here